{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:37:02Z","timestamp":1793137022905,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX23_3407"],"award-info":[{"award-number":["KYCX23_3407"]}]},{"name":"the Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX25_3777"],"award-info":[{"award-number":["KYCX25_3777"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070505"],"award-info":[{"award-number":["82070505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["BK20211330"],"award-info":[{"award-number":["BK20211330"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-025-02159-5","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:43:34Z","timestamp":1767879814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["N4BP1 acts as a potent negative regulator of IL-17 signaling by blocking the translation of Act1 mRNA"],"prefix":"10.1007","volume":"75","author":[{"given":"Yanli","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuolong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsheng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peida","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"2159_CR1","doi-asserted-by":"publisher","first-page":"885609","DOI":"10.3389\/fimmu.2022.885609","volume":"13","author":"L Wei","year":"2022","unstructured":"Wei L, Abraham D, Ong V. The yin and yang of IL-17 in systemic sclerosis. Front Immunol. 2022;13:885609.","journal-title":"Front Immunol"},{"key":"2159_CR2","doi-asserted-by":"publisher","first-page":"111897","DOI":"10.1016\/j.celrep.2022.111897","volume":"41","author":"FP Veras","year":"2022","unstructured":"Veras FP, Publio GA, Melo BM, Prado DS, Norbiato T, Cecilio NT, Hiroki C, Damasceno L, Jung R, Toller-Kawahisa JE, Martins TV, Assuncao SF, Lima D, Alves MG, Vieira GV, Tavares LA, Alves-Rezende A, Karbach SH, Nakaya HI, Cunha TM, Souza CS, Cunha FQ, Sales KU, Waisman A, Alves-Filho JC. Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation. Cell Rep. 2022;41:111897.","journal-title":"Cell Rep"},{"key":"2159_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41423-023-00973-7","volume":"20","author":"W Yang","year":"2023","unstructured":"Yang W, He R, Qu H, Lian W, Xue Y, Wang T, Lin W, Zhu P, Xia M, Lai L, Wang Q. FXYD3 enhances IL-17A signaling to promote psoriasis by competitively binding TRAF3 in keratinocytes. Cell Mol Immunol. 2023;20:292.","journal-title":"Cell Mol Immunol"},{"key":"2159_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41590-022-01339-3","volume":"23","author":"X Ni","year":"2022","unstructured":"Ni X, Xu Y, Wang W, Kong B, Ouyang J, Chen J, Yan M, Wu Y, Chen Q, Wang X, Li H, Gao X, Guo H, Cui L, Chen Z, Shi Y, Zhu R, Li W, Shi T, Wang LF, Huang J, Dong C, Lai Y. IL-17D-induced Inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation. Nat Immunol. 2022;23:1577.","journal-title":"Nat Immunol"},{"key":"2159_CR5","doi-asserted-by":"publisher","first-page":"1271342","DOI":"10.3389\/fimmu.2023.1271342","volume":"14","author":"L Camargo","year":"2023","unstructured":"Camargo L, Righetti RF, de Almeida FM, Dos ST, Fukuzaki S, Martins N, Barbeiro MC, Saraiva-Romanholo BM, Lopes F, Leick EA, Prado CM, Tiberio I. Modulating asthma-COPD overlap responses with IL-17 inhibition. Front Immunol. 2023;14:1271342.","journal-title":"Front Immunol"},{"key":"2159_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4196\/kjpp.2019.23.4.251","volume":"23","author":"Q Huang","year":"2019","unstructured":"Huang Q, Han L, Lv R, Ling L. Magnolol exerts anti-asthmatic effects by regulating Janus kinase-signal transduction and activation of transcription and Notch signaling pathways and modulating Th1\/Th2\/Th17 cytokines in ovalbumin-sensitized asthmatic mice. Korean J Physiol Pharmacol. 2019;23:251.","journal-title":"Korean J Physiol Pharmacol"},{"key":"2159_CR7","doi-asserted-by":"crossref","unstructured":"Kondo N, Kuroda T, Kobayashi D. Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci 2021;22:10922.","DOI":"10.3390\/ijms222010922"},{"key":"2159_CR8","doi-asserted-by":"publisher","first-page":"109714","DOI":"10.1016\/j.intimp.2023.109714","volume":"115","author":"W Sun","year":"2023","unstructured":"Sun W, Ma J, Chen M, Zhang W, Xu C, Nan Y, Wu W, Mao X, Cheng X, Cai H, Zhang J, Xu H, Wang Y. 4-Iodo-6-phenylpyrimidine (4-IPP) suppresses fibroblast-like synoviocyte- mediated inflammation and joint destruction associated with rheumatoid arthritis. Int Immunopharmacol. 2023;115:109714.","journal-title":"Int Immunopharmacol"},{"key":"2159_CR9","doi-asserted-by":"publisher","first-page":"637829","DOI":"10.3389\/fimmu.2021.637829","volume":"12","author":"C Schinocca","year":"2021","unstructured":"Schinocca C, Rizzo C, Fasano S, Grasso G, La Barbera L, Ciccia F, Guggino G. Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview. Front Immunol. 2021;12:637829.","journal-title":"Front Immunol"},{"key":"2159_CR10","doi-asserted-by":"publisher","first-page":"108675","DOI":"10.1016\/j.intimp.2022.108675","volume":"107","author":"Y Geng","year":"2022","unstructured":"Geng Y, Yang J, Cheng X, Han Y, Yan F, Wang C, Jiang X, Meng X, Fan M, Zhao M, Zhu L. A bioactive gypenoside (GP-14) alleviates neuroinflammation and blood brain barrier (BBB) disruption by inhibiting the NF-kappaB signaling pathway in a mouse high-altitude cerebral edema (HACE) model. Int Immunopharmacol. 2022;107:108675.","journal-title":"Int Immunopharmacol"},{"key":"2159_CR11","doi-asserted-by":"publisher","first-page":"107212","DOI":"10.1016\/j.intimp.2020.107212","volume":"90","author":"Y Xu","year":"2021","unstructured":"Xu Y, Cai R, Zhao Z, Zhou L, Zhou Q, Hassan S, Huang S, Zhang M, Xu G, Zou X. Thiomyristoyl ameliorates colitis by blocking the differentiation of Th17 cells and inhibiting SIRT2-induced metabolic reprogramming. Int Immunopharmacol. 2021;90:107212.","journal-title":"Int Immunopharmacol"},{"key":"2159_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerback C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021;397:754.","journal-title":"Lancet"},{"key":"2159_CR13","doi-asserted-by":"crossref","unstructured":"Vidal S, Puig L, Carrascosa-Carrillo JM, Gonzalez-Cantero A, Ruiz-Carrascosa JC, Velasco-Pastor AM. From messengers to receptors in psoriasis: the role of IL-17RA in disease and treatment. Int J Mol Sci 2021;22:6740.","DOI":"10.3390\/ijms22136740"},{"key":"2159_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41590-018-0071-9","volume":"19","author":"T Herjan","year":"2018","unstructured":"Herjan T, Hong L, Bubenik J, Bulek K, Qian W, Liu C, Li X, Chen X, Yang H, Ouyang S, Zhou H, Zhao J, Vasu K, Cockman E, Aronica M, Asosingh K, Licatalosi DD, Qin J, Fox PL, Hamilton TA, Driscoll D, Li X. IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling. Nat Immunol. 2018;19:354.","journal-title":"Nat Immunol"},{"key":"2159_CR15","doi-asserted-by":"crossref","unstructured":"Garg AV, Amatya N, Chen K, Cruz JA, Grover P, Whibley N, Conti HR, Hernandez MG, Sirakova T, Childs EC, Smithgall TE, Biswas PS, Kolls JK, McGeachy MJ, Kolattukudy PE, Gaffen SL. MCPIP1 endoribonuclease activity negatively regulates interleukin-17-mediated signaling and inflammation. Immunity. 2015;43:475.","DOI":"10.1016\/j.immuni.2015.07.021"},{"key":"2159_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/jir.2021.0171","volume":"42","author":"T Herjan","year":"2022","unstructured":"Herjan T, Xiao J, Dziendziel KM. RNA-binding protein HuR promotes airway inflammation in a house dust mite-Induced allergic asthma model. J Interferon Cytokine Res. 2022;42:29.","journal-title":"J Interferon Cytokine Res"},{"key":"2159_CR17","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1128\/MCB.00268-12","volume":"32","author":"F Qu","year":"2012","unstructured":"Qu F, Gao H, Zhu S, Shi P, Zhang Y, Liu Y, Jallal B, Yao Y, Shi Y, Qian Y. TRAF6-dependent Act1 phosphorylation by the IkappaB kinase-related kinases suppresses interleukin-17-induced NF-kappaB activation. Mol Cell Biol. 2012;32:3925.","journal-title":"Mol Cell Biol"},{"key":"2159_CR18","doi-asserted-by":"publisher","first-page":"112716","DOI":"10.1016\/j.intimp.2024.112716","volume":"139","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Li Z, Chen Y, Nie N, Liu X, Liu J, Shen Y. MLN4924 alleviates autoimmune myocarditis by promoting Act1 degradation and blocking Act1-mediated mRNA stability. Int Immunopharmacol. 2024;139:112716.","journal-title":"Int Immunopharmacol"},{"key":"2159_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41435-017-0007-7","volume":"20","author":"N Yu","year":"2019","unstructured":"Yu N, Lambert S, Bornstein J, Nair RP, Enerback C, Elder JT. The Act1 D10N missense variant impairs CD40 signaling in human B-cells. Genes Immun. 2019;20:23.","journal-title":"Genes Immun"},{"key":"2159_CR20","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1159\/000491810","volume":"48","author":"H Sun","year":"2018","unstructured":"Sun H, Zhong D, Wang C, Sun Y, Zhao J, Li G. MiR-298 exacerbates ischemia\/reperfusion injury following ischemic stroke by targeting Act1. Cell Physiol Biochem. 2018;48:528.","journal-title":"Cell Physiol Biochem"},{"key":"2159_CR21","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1074\/jbc.M110047200","volume":"277","author":"R Murillas","year":"2002","unstructured":"Murillas R, Simms KS, Hatakeyama S, Weissman AM, Kuehn MR. Identification of developmentally expressed proteins that functionally interact with Nedd4 ubiquitin ligase. J Biol Chem. 2002;277:2897.","journal-title":"J Biol Chem"},{"key":"2159_CR22","doi-asserted-by":"publisher","first-page":"109983","DOI":"10.1016\/j.biopha.2020.109983","volume":"125","author":"H He","year":"2020","unstructured":"He H, Huang C, Chen Z, Huang H, Wang X, Chen J. An outlined review for the role of Nedd4-1 and Nedd4-2 in lung disorders. Biomed Pharmacother. 2020;125:109983.","journal-title":"Biomed Pharmacother"},{"key":"2159_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-020-2796-5","volume":"587","author":"AD Gitlin","year":"2020","unstructured":"Gitlin AD, Heger K, Schubert AF, Reja R, Yan D, Pham VC, Suto E, Zhang J, Kwon YC, Freund EC, Kang J, Pham A, Caothien R, Bacarro N, Hinkle T, Xu M, McKenzie BS, Haley B, Lee WP, Lill JR, Roose-Girma M, Dohse M, Webster JD, Newton K, Dixit VM. Integration of innate immune signalling by caspase-8 cleavage of N4BP1. Nature. 2020;587:275.","journal-title":"Nature"},{"key":"2159_CR24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2024.04.004","volume":"57","author":"AD Gitlin","year":"2024","unstructured":"Gitlin AD, Maltzman A, Kanno Y, Heger K, Reja R, Schubert AF, Wierciszewski LJ, Pantua H, Kapadia SB, Harris SF, Webster JD, Newton K, Dixit VM. N4BP1 coordinates ubiquitin-dependent crosstalk within the IkappaB kinase family to limit Toll-like receptor signaling and inflammation. Immunity. 2024;57:973.","journal-title":"Immunity"},{"key":"2159_CR25","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41467-021-21711-5","volume":"12","author":"H Shi","year":"2021","unstructured":"Shi H, Sun L, Wang Y, Liu A, Zhan X, Li X, Tang M, Anderton P, Hildebrand S, Quan J, Ludwig S, Moresco E, Beutler B. N4BP1 negatively regulates NF-kappaB by binding and inhibiting NEMO oligomerization. Nat Commun. 2021;12:1379.","journal-title":"Nat Commun"},{"key":"2159_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41420-024-01913-8","volume":"10","author":"KW Kliza","year":"2024","unstructured":"Kliza KW, Song W, Pinzuti I, Schaubeck S, Kunzelmann S, Kuntin D, Fornili A, Pandini A, Hofmann K, Garnett JA, Stieglitz B, Husnjak K. N4BP1 functions as a dimerization-dependent linear ubiquitin reader which regulates TNF signalling. Cell Death Discov. 2024;10:183.","journal-title":"Cell Death Discov"},{"key":"2159_CR27","doi-asserted-by":"publisher","first-page":"107954","DOI":"10.1016\/j.jbc.2024.107954","volume":"300","author":"W Zheng","year":"2024","unstructured":"Zheng W, Guo J, Ma S, Sun R, Song Y, Chen Y, Mao R, Fan Y. The NEDD4-binding protein N4BP1 degrades mRNA substrates through the coding sequence independent of nonsense-mediated decay. J Biol Chem. 2024;300:107954.","journal-title":"J Biol Chem"},{"key":"2159_CR28","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41419-021-03774-w","volume":"12","author":"C Gou","year":"2021","unstructured":"Gou C, Ni W, Ma P, Zhao F, Wang Z, Sun R, Wu Y, Wu Y, Chen M, Chen H, Zhang J, Shen Y, Xiao M, Lu C, Mao R, Fan Y. The endoribonuclease N4BP1 prevents psoriasis by controlling both keratinocytes proliferation and neutrophil infiltration. Cell Death Dis. 2021;12:488.","journal-title":"Cell Death Dis"},{"key":"2159_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.20892\/j.issn.2095-3941.2021.0137","volume":"19","author":"P Ma","year":"2021","unstructured":"Ma P, Jin X, Fan Z, Wang Z, Yue S, Wu C, Chen S, Wu Y, Chen M, Gu D, Zhang S, Mao R, Fan Y. Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin\/BRAF\/TAK1\/ERK\/ETV4 signaling. Cancer Biol Med. 2021;19:669.","journal-title":"Cancer Biol Med"},{"key":"2159_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","volume":"576","author":"J Wei","year":"2019","unstructured":"Wei J, Long L, Zheng W, Dhungana Y, Lim SA, Guy C, Wang Y, Wang YD, Qian C, Xu B, Kc A, Saravia J, Huang H, Yu J, Doench JG, Geiger TL, Chi H. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576:471.","journal-title":"Nature"},{"key":"2159_CR31","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.4049\/jimmunol.1300832","volume":"191","author":"Q Luo","year":"2013","unstructured":"Luo Q, Sun Y, Liu W, Qian C, Jin B, Tao F, Gu Y, Wu X, Shen Y, Xu Q. A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide. J Immunol. 2013;191:4969.","journal-title":"J Immunol"},{"key":"2159_CR32","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.immuni.2023.06.012","volume":"56","author":"Q Luo","year":"2023","unstructured":"Luo Q, Liu Y, Shi K, Shen X, Yang Y, Liang X, Lu L, Qiao W, Chen A, Hong D, Sun Y, Xu Q. An autonomous activation of interleukin-17 receptor signaling sustains inflammation and promotes disease progression. Immunity. 2023;56:2006.","journal-title":"Immunity"},{"key":"2159_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","volume":"38","author":"N Amatya","year":"2017","unstructured":"Amatya N, Garg AV, Gaffen SL. IL-17 signaling: the yin and the yang. Trends Immunol. 2017;38:310.","journal-title":"Trends Immunol"},{"key":"2159_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","volume":"8","author":"L Huangfu","year":"2023","unstructured":"Huangfu L, Li R, Huang Y, Wang S. The IL-17 family in diseases: from bench to bedside. Signal Transduct Target Ther. 2023;8:402.","journal-title":"Signal Transduct Target Ther"},{"key":"2159_CR35","doi-asserted-by":"publisher","first-page":"35603","DOI":"10.1074\/jbc.C600256200","volume":"281","author":"SH Chang","year":"2006","unstructured":"Chang SH, Park H, Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem. 2006;281:35603.","journal-title":"J Biol Chem"},{"key":"2159_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni1439","volume":"8","author":"Y Qian","year":"2007","unstructured":"Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, Xiao J, Lu Y, Giltiay N, Liu J, Kordula T, Zhang QW, Vallance B, Swaidani S, Aronica M, Tuohy VK, Hamilton T, Li X. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol. 2007;8:247.","journal-title":"Nat Immunol"},{"key":"2159_CR37","doi-asserted-by":"crossref","unstructured":"Amatya N, Childs EE, Cruz JA, Aggor F, Garg AV, Berman AJ, Gudjonsson JE, Atasoy U, Gaffen SL. IL-17 integrates multiple self-reinforcing, feed-forward mechanisms through the RNA binding protein Arid5a. SCI SIGNAL 2018;11:eaat4617.","DOI":"10.1126\/scisignal.aat4617"},{"key":"2159_CR38","doi-asserted-by":"publisher","first-page":"e113383","DOI":"10.15252\/embj.2022113383","volume":"42","author":"Z Ma","year":"2023","unstructured":"Ma Z, Zeng Y, Wang M, Liu W, Zhou J, Wu C, Hou L, Yin B, Qiang B, Shu P, Peng X. N4BP1 mediates RAM domain-dependent Notch signaling turnover during neocortical development. EMBO J. 2023;42:e113383.","journal-title":"EMBO J"},{"key":"2159_CR39","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1158\/0008-5472.CAN-18-0545","volume":"78","author":"L Spel","year":"2018","unstructured":"Spel L, Nieuwenhuis J, Haarsma R, Stickel E, Bleijerveld OB, Altelaar M, Boelens JJ, Brummelkamp TR, Nierkens S, Boes M. Nedd4-Binding protein 1 and TNFAIP3-Interacting protein 1 control MHC-1 display in neuroblastoma. Cancer Res. 2018;78:6621.","journal-title":"Cancer Res"},{"key":"2159_CR40","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3892\/ijo.2017.3915","volume":"50","author":"J Xu","year":"2017","unstructured":"Xu J, Jiang N, Shi H, Zhao S, Yao S, Shen H. miR-28-5p promotes the development and progression of ovarian cancer through Inhibition of N4BP1. Int J Oncol. 2017;50:1383.","journal-title":"Int J Oncol"},{"key":"2159_CR41","doi-asserted-by":"publisher","first-page":"110850","DOI":"10.1016\/j.cellsig.2023.110850","volume":"110","author":"C Wu","year":"2023","unstructured":"Wu C, Guo X, Zheng W, Sun R, Chen L, Shen Y, Chen M, Song Y, Mao R, Chen X, Fan Y. N4BP1 regulates keratinocytes development and plays protective role in burn- and adhesive-related skin injury via MMP9. Cell Signal. 2023;110:110850.","journal-title":"Cell Signal"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02159-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02159-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02159-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:43:36Z","timestamp":1767879816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02159-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2159"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02159-5","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}